Mark Bachleda - 09 Jun 2025 Form 3 Insider Report for Lyell Immunopharma, Inc. (LYEL)

SEC form
3
Accepted by SEC
11 Jun 2025, 17:42:27 UTC
Prior SEC filing
20 Mar 2023
Next SEC filing
12 Jun 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Mark Bachleda filed Form 3 for Lyell Immunopharma, Inc. (LYEL) on 11 Jun 2025.

Key facts

  • This page summarizes Mark Bachleda's Form 3 filing for Lyell Immunopharma, Inc. (LYEL).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Jun 2025, 17:42.

Change

  • Previous filing in this sequence was filed on 20 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001887762 Primary reporting owner

Bachleda Mark

Relationship
Director

Additional SEC filing notes

Filing notes and footnotes

Ownership status

The filing reports no beneficially owned securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .